Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.
It seems too simple to be true that we could shine a light in someone’s eyes for a few minutes nine times every 4 months and that it would help either regenerate or slow the aging process in the retina. The premise is that shining a combination of three wavelengths of light (590 nm, 660 nm and 850 nm) into the eye helps activate the mitochondria in retinal cells.
The study to gain FDA authorization was relatively small, 148 eyes over 2